3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
3
Neoplasm Metastasis
2
Thymoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Melanoma
1
Lymphatic Metastasis
1
Head and Neck Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 10
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Interventions
fludarabine phosphate
2
Whole-Body Irradiation
2
Melphalan
2
Cyclophosphamide
2
Busulfan
2
asciminib
1
Tyrosine Kinase Inhibitors
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Rituximab
1
Pharmaceutical Preparations
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methotrexate
1
Etoposide
1
Cyclosporine
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
CT-P10
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic-Phase
×
avelumab
×
30 days
×
Clear all
No trials found.